Cogent Biosciences (COGT) Leases (2019 - 2021)
Cogent Biosciences (COGT) has 3 years of Leases data on record, last reported at $3.2 million in Q3 2021.
- For Q3 2021, Leases fell 35.61% year-over-year to $3.2 million; the TTM value through Sep 2021 reached $3.2 million, down 35.61%, while the annual FY2020 figure was $4.6 million, 12.68% down from the prior year.
- Leases reached $3.2 million in Q3 2021 per COGT's latest filing, down from $3.7 million in the prior quarter.
- Across five years, Leases topped out at $6.3 million in Q1 2019 and bottomed at $3.2 million in Q3 2021.
- Average Leases over 3 years is $4.9 million, with a median of $4.9 million recorded in 2020.
- Peak YoY movement for Leases: dropped 10.44% in 2020, then tumbled 35.61% in 2021.
- A 3-year view of Leases shows it stood at $5.3 million in 2019, then fell by 12.68% to $4.6 million in 2020, then dropped by 29.6% to $3.2 million in 2021.
- Per Business Quant database, its latest 3 readings for Leases were $3.2 million in Q3 2021, $3.7 million in Q2 2021, and $4.2 million in Q1 2021.